SR9009

SR9009 functions as a REV-ERBα agonist. This means it binds to and activates the Rev-erb alpha receptor, a nuclear hormone receptor crucial in regulating circadian rhythms and metabolic processes. Activation of this receptor influences lipid metabolism, glucose homeostasis, and inflammation. Specifically, users report that SR9009 increases mitochondrial biogenesis – the creation of new mitochondria within cells – leading to enhanced energy production. This increased metabolic activity may contribute to improved fat oxidation and endurance performance. Athletes typically run SR9009 with the expectation of mimicking some effects of exercise on a cellular level, though individual responses vary.

SR9009 is primarily investigated for its potential in cutting cycles due to its effects on fat metabolism. Researchers explore its ability to increase energy expenditure and promote lipolysis (fat breakdown). Some studies suggest it may also improve insulin sensitivity, which can be beneficial during periods of caloric restriction. While less common, some researchers investigate SR9009's impact on endurance capacity, hypothesizing that increased mitochondrial density could enhance aerobic performance. It is not typically used in bulking cycles or as a direct strength-enhancing compound; its focus remains firmly on metabolic effects.

Advanced users report typical dosages ranging from 50 mg to 100 mg per day, administered orally. Cycles typically run for 4-8 weeks, followed by a period of rest or reduced dosage. Intermediate users may start with 25 mg/day and gradually increase as tolerated. It’s crucial to dissolve SR9009 in a carrier oil (e.g., MCT oil) for optimal absorption. Bloodwork is strongly recommended before starting and throughout the cycle to monitor liver enzymes, lipid panels, and overall health. Pharmacom SR9009 products are often available in 10mg/mL concentrations, allowing for precise dosing.

Users report potential side effects including liver stress (elevated liver enzymes), changes in body temperature, and gastrointestinal discomfort. Hepatotoxicity is a primary concern; therefore, regular bloodwork is essential to monitor liver function. Due to its impact on metabolic processes, SR9009 may disrupt natural hormone balance. It’s recommended for users over the age of 21 with no pre-existing medical conditions. A Post Cycle Therapy (PCT) protocol is not typically necessary after an SR9009 cycle, but supportive liver support supplements are often employed to aid recovery and maintain optimal health. It's important to note that long-term effects remain largely unknown.

Mechanism of action

SR9009 directly activates the REV-ERBα receptor, influencing circadian rhythms, lipid metabolism, glucose homeostasis, and inflammation through modulation of gene expression involved in energy expenditure.